Aspirin And Extended - Release Dipyridamole Capsules, 25 Mg / 200 Mg Capsule
Product Images NDC 0904-7056

4 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aspirin And Extended - Release Dipyridamole Capsules, 25 Mg / 200 Mg (NDC 0904-7056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton Label (0cc3d781 846e 4f18 848e 2b4c2571e6a4 00)

Carton Label (0cc3d781 846e 4f18 848e 2b4c2571e6a4 00)
Label for Aspirin and Extended-Release Dipyridamole Capsules 25 mg/200 mg by Major Pharmaceuticals. The unit dose label shows 20 capsules and states the prescription-only status. The label includes dosage, storage instructions, and distributor information for MAJOR Pharmaceuticals in Livonia, MI.*
FDA Label Image

Dipyridamole (Aspirin And Extended Release Dypyridamole Capsules 1)

Dipyridamole (Aspirin And Extended Release Dypyridamole Capsules 1)
Chemical structure of the active ingredient Extended-Release Dipyridamole, showing its molecular formula (C24H40N8O4) and molecular weight (504.63).*
FDA Label Image

Aspirin (Aspirin And Extended Release Dypyridamole Capsules 2)

Aspirin (Aspirin And Extended Release Dypyridamole Capsules 2)
Chemical structure diagram of aspirin as part of the Aspirin and Extended-Release Dipyridamole Capsules formulation. The image shows the molecular formula C9H8O4 and molecular weight 180.16.*
FDA Label Image

Aspirin (Aspirin And Extended Release Dypyridamole Capsules 3)

Aspirin (Aspirin And Extended Release Dypyridamole Capsules 3)
A line graph showing the cumulative stroke rate (%) over 24 months of follow-up across three treatment groups: aspirin and extended-release dipyridamole (stars), aspirin (triangles), and extended-release dipyridamole (diamonds), compared to placebo (circles). The x-axis represents months of follow-up, and the y-axis shows cumulative stroke rate percentages, illustrating stroke incidence trends over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.